A detailed history of Inscription Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Inscription Capital, LLC holds 32,013 shares of PFE stock, worth $852,186. This represents 0.14% of its overall portfolio holdings.

Number of Shares
32,013
Previous 36,396 12.04%
Holding current value
$852,186
Previous $1.02 Million 9.04%
% of portfolio
0.14%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $121,409 - $137,582
-4,383 Reduced 12.04%
32,013 $926,000
Q2 2024

Jul 17, 2024

SELL
$25.26 - $29.6 $45,164 - $52,924
-1,788 Reduced 4.68%
36,396 $1.02 Million
Q1 2024

Jul 17, 2024

BUY
$25.89 - $29.73 $988,583 - $1.14 Million
38,184 New
38,184 $1.06 Million
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $50,012 - $64,961
1,914 Added 13.3%
16,309 $469,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $30,100 - $35,184
-938 Reduced 6.12%
14,395 $477,000
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $4,876 - $5,641
135 Added 0.89%
15,333 $562,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $186,866 - $243,272
-4,744 Reduced 23.79%
15,198 $620,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $12,525 - $16,350
300 Added 1.53%
19,942 $1.02 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.09 Million - $1.33 Million
-24,844 Reduced 55.85%
19,642 $860,000
Q2 2022

Sep 20, 2022

BUY
$46.53 - $55.17 $1.18 Million - $1.4 Million
25,334 Added 132.28%
44,486 $2.33 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $9,150 - $11,338
-200 Reduced 1.03%
19,152 $992,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $326,841 - $484,487
7,910 Added 69.13%
19,352 $1.14 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $15.8 Million - $20.3 Million
-402,135 Reduced 97.23%
11,442 $492,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $14.4 Million - $16.4 Million
401,991 Added 3469.63%
413,577 $16.2 Million
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $130,845 - $147,567
3,907 Added 50.88%
11,586 $420,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $8,568 - $10,895
256 Added 3.45%
7,679 $283,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $235,680 - $276,506
7,423 New
7,423 $272,000
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $196,472 - $238,350
-6,523 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $176,316 - $251,918
6,523 New
6,523 $213,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $36,980 - $41,520
-1,000 Closed
0 $0
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $37,500 - $41,200
1,000 New
1,000 $42,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.